Intensity Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
INTS Key Statistics
Stock Snapshot
With a market cap of 9.71M, Intensity Therapeutics(INTS) trades at $3.10. The stock has a price-to-earnings ratio of -0.72.
On 2026-11-05, Intensity Therapeutics(INTS) stock traded between a low of $2.80 and a high of $3.49. Shares are currently priced at $3.10, which is +10.7% above the low and -11.2% below the high.
Intensity Therapeutics(INTS) shares are trading with a volume of 50.13K, against a daily average of 8.22K.
During the past year, Intensity Therapeutics(INTS) stock moved between $2.80 at its lowest and $15.75 at its peak.
During the past year, Intensity Therapeutics(INTS) stock moved between $2.80 at its lowest and $15.75 at its peak.
INTS News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.